Each month, the NATA scientific committee organises a one-hour interactive session led by top experts, featuring a hot topic related to clinical practice.
Registered participants can submit questions during the session.
Associate Consultant and Specialist in Immunology and Transfusion Medicine,
Department of Immunology and Transfusion Medicine,
Oslo University Hospital, Oslo, Norway
Medical Intensive Care
University of Bretagne Occidental and Teaching Brest Hospital
The reasons why the available evidence on red blood cell transfusion cannot be extrapolated to oncologic patients will be discussed. The available literature to guide our transfusion practice will be described. The need for future research to define the optimal transfusion strategy will be emphasized.
Consultant in Anaesthesia and Peri-operative Medicine
The Royal Marsden NHS Foundation Trust
London , UK
The topic will cover current issues in anaemia diagnosis in cancer , high risk groups , timing of treatment in cancer journey and treatment options. In particular the topic will address the limitations of oral iron , role of intravenous iron therapy in cancer , vitamin supplements and erythropoietin in cancer . We will also discuss recent guidelines in anaemia management in cancer